乌鸦传媒

<乌鸦传媒 class="page-title">Meeting Coverage

ACG Video Pearls

<乌鸦传媒 class="page-description">Video Pearls from the American College of Gastroenterology
Biologic Therapy for IBD Not Tied to Higher Risk of Major Heart Events

Newer agents also associated with lower VTE risk versus non-advanced treatments

image
<乌鸦传媒 class="section_title">Latest ACG Video Pearls Meeting Coverage
How to Position the Growing Number of Therapies in IBD

"Exciting time" to treat Crohn's disease and ulcerative colitis, expert says

November 21, 2023
New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks

More than half of patients not in early clinical response at week 12 responded by week 24

November 14, 2023
Guselkumab Shows Early Symptom Improvement in UC

Jessica Allegretti, MD, offers an update from the phase III QUASAR induction study

November 7, 2023
Bloating, Abdominal Pain Are 'Driving Factors' in Global IBS-D Symptom Scores

Stool consistency was only found to have a moderate correlation

December 1, 2022
IgG-Guided Elimination Diet Promising for Irritable Bowel Syndrome

Improved global endpoints compared with sham diet, says Anthony Lembo, MD

November 23, 2022
Plecanatide for Severe Abdominal Pain, Bloating in IBS-Constipation

Treatment eases severe symptoms, pooled analysis of phase III trials showed

November 17, 2022
Rifaximin Improves Fecal Urgency and Stool Consistency in IBS With Diarrhea

Brooks Cash, MD, discusses his post-hoc analysis of the TARGET 1 and TARGET 2 studies

November 10, 2022
<乌鸦传媒 class="section_title"> Latest Gastroenterology Meeting Coverage